InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: falconer66a post# 113085

Friday, 07/28/2017 8:48:13 AM

Friday, July 28, 2017 8:48:13 AM

Post# of 464101
Look at this

http://www.vtvtherapeutics.com/assets/docs/Burstein_AAIC_2016_Azeliragon_Responder_Analysis_27July2016_final.pdf

It looks good on paper but have not been received well. So they completed enrollment for next trial.

Most of the drugs that reached P2 or P3 showed promising results in early stages - the companies were too excited about them same way AVXL is.

Well how much one can get excited about inconclusive results about 25 patient trial ?

This is not like a cancer drug that shows very high tumor shrinkage in P1 which is conclusive evidence not a graph that one tries to split to get evidence.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News